Hatty Cadman leads the Healthcare practice at MBS. She brings a deep understanding of leadership and of boards, a passion for the vibrancy, innovation and impact of healthcare businesses, and an absolute commitment to client service excellence. She has worked with boards, investors and owners for more than two decades, advising on executive and non-executive appointments, as well as on board review and development, and on-boarding.
Across healthcare, she has delivered CEO, Chair, and clinical and functional leadership appointments to businesses across healthcare, clinical services, digital health, and research and innovation. She has also worked with UK government and the NHS, on CEO, Chair and NED, Medical Director and Chief Scientific Adviser appointments, amongst others.
Prior to joining MBS, Hatty spent a decade with Russell Reynolds Associates before leading the Healthcare practice at a board-level boutique search firm, where she also co-authored the business’s diversity and inclusion plan. She graduated in History from the University of Oxford.
Contact Hatty Cadman by email
You’ll be able to unsubscribe at any time.
THE MBS GROUP LTD
3 Primose Mews
Sharpleshall Street
London NW1 8YW
UK
Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.